Your session is about to expire
← Back to Search
Behavioural Intervention
High Fat Meal for Sleep Deprivation
N/A
Waitlist Available
Led By Jill Kanaley, PhD
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hour
Awards & highlights
Study Summary
This trial seeks to understand if sleep restriction can negate the positive effects of exercise on postprandial lipemia. #SleepLoss & #Exercise effects on lipid profile will be tested. ANOVA will measure changes in NEFA & TG concentrations.
Eligible Conditions
- Obesity
- Sleep Deprivation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 hour
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hour
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
area under the curve of fatty acids concentrations
area under the curve of triglycerides concentrations
Secondary outcome measures
area under the curve of glucose concentrations
Trial Design
4Treatment groups
Experimental Treatment
Placebo Group
Group I: no exercise, SRExperimental Treatment1 Intervention
75 g of glucose will be given at the beginning of the study day (the evening prior there will be no exercise the night before the study day, 4 h of sleep the previous night)
Group II: Exercise, no SRExperimental Treatment1 Intervention
75 g of glucose will be given at the beginning of the study day (the evening prior there will be 45 min of exercise the night before the study day, normal sleep (8 h))
Group III: Exercise, SRExperimental Treatment1 Intervention
75 g of glucose will be given at the beginning of the study day (the evening prior there will be 45 min of exercise the night before the study day, 4 h of sleep the previous night)
Group IV: no exercise, no SRPlacebo Group1 Intervention
75 g of glucose will be given at the beginning of the study day (the evening prior there will be no exercise the night before the study day, normal sleep (8 h))
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
high fat meal
2022
Completed Phase 1
~70
Find a Location
Who is running the clinical trial?
University of Missouri-ColumbiaLead Sponsor
365 Previous Clinical Trials
628,227 Total Patients Enrolled
20 Trials studying Obesity
2,192 Patients Enrolled for Obesity
Jill Kanaley, PhDPrincipal InvestigatorUniversity of Missouri-Columbia
7 Previous Clinical Trials
299 Total Patients Enrolled
2 Trials studying Obesity
37 Patients Enrolled for Obesity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Having trouble sleeping through the night.You are taking medications that affect how your body processes food, how hungry you feel, or how well you sleep.You have been diagnosed with type 2 diabetes.You have been diagnosed with heart or blood vessel disease.You have high blood pressure.People who smoke.You are currently taking medications to lower your cholesterol.You have been told that you have sleep apnea.You work at night or take regular naps during the day.You are allergic to milk, ice cream, peanut butter, or soy.People who weigh more than they should for their height.You are between 21 and 45 years old.You typically sleep for 7-9 hours each night.Your body mass index (BMI) is between 25 and 35.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise, SR
- Group 2: no exercise, no SR
- Group 3: no exercise, SR
- Group 4: Exercise, no SR
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Obesity Patient Testimony for trial: Trial Name: NCT05713370 — N/A
Share this study with friends
Copy Link
Messenger